2013 SABCS Public All Photos
Read More
San Antonio, TX -SABCS 2013 San Antonio Breast Cancer Symposium: Dennis J Slamon addresses General Session 1 about S1-03. Primary results from BETH, a phase 3 controlled study of adjuvant chemotherapy and trastuzumab ± bevacizumab in patients with HER2-positive, node-positive or high risk node-negative breast cancer session at the 2013 San Antonio Breast Cancer Symposium here today, Wednesday December 11, 2013. Over 7500 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention.
Photo by © SABCS/Todd Buchanan 2013 Technical Questions: todd@medmeetingimages.com
